Israel - Hebrew - Ministry of Health

zoetis israel holding b.v., israel - selamectin - תמיסה - selamectin 60 mg/ml

Israel - Hebrew - Ministry of Health

zoetis israel holding b.v., israel - selamectin - תמיסה - selamectin 120 mg/ml

Israel - Hebrew - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 16 mg

Israel - Hebrew - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 3.6 mg

Israel - Hebrew - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 5.4 mg

Israel - Hebrew - Ministry of Health

zoetis israel holding b.v., israel - sarolaner; selamectin - תמיסה - sarolaner 10 mg / 1 ml; selamectin 60 mg / 1 ml

Israel - Hebrew - Ministry of Health

zoetis israel holding b.v., israel - sarolaner - טבליות לעיסות - sarolaner 5 mg

Israel - Hebrew - Ministry of Health

bayer israel ltd - norethisterone acetate - טבליה - norethisterone acetate 5 mg - norethisterone - norethisterone - oral progestron for: dysfunctional bleeding, primary and secondary amenorrhea, premenstrual syndrome, timing of mensturation and endometriosis.

Israel - Hebrew - Ministry of Health

padagis israel agencies ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).

Israel - Hebrew - Ministry of Health

inspire md ltd - רופא - mguard prime coronary stent system is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • treatment of coronary lesion in patients undergoing primary or rescue pci for acute st-segment elevation myocardial infarction(stemi) • treatment of coronary lesion having atherothrombotic appearance in patients with non st-elevation acute coronary syndromes (unstable angina and non st-segment elevation myocardial infarction).